Global Cardiac Surgery Devices Market

Description

Market Overview

Cardiac Surgery Devices Market is estimated to reach at a CAGR of 8.4% during the forecast period (2022-2029).

Heart surgeons perform cardiac surgery due to the complications in the heart like congenital heart disease, ischemic heart disease, valvular heart disease, etc. Manufacturers of cardiac devices are developing novel instruments along with traditional devices to offer more usable products in treating cardiac diseases.

Market Dynamics

The major driving forces are the rising heart disease prevalence, the growing geriatric population, and technological advancements.

The increasing prevalence of cardiovascular disease and rising geriatric population are propelling the global market growth.

The increasing incidences of cardiovascular diseases are expected to boost the market over the forecast period. For instance, according to the British Heart Foundation, around 168,319 people died in 2020 from cardiovascular diseases. Cardiovascular diseases are rising due to various predisposing factors; examples of a few are the growing geriatric population, rising disposable income, changing lifestyles, smoking, and others; for instance, the world health organization data indicated that in 2020, there were around 1 billion people aged 60 and above. It is estimated that by 2050 the geriatric population will reach 2.1 billion. In addition to this, as per the World Health Organization, tobacco consumption has claimed over 8 million deaths every year globally, of which nearly 7 million are because of the direct use of tobacco, while close to 1.2 million are as a result of non-smokers exposed to secondhand smoke.

The stringent regulations and lack of cardiac surgeons hinder the global cardiac surgery devices market growth.

However, the stringent regulations for the approval of medical devices, high investment cost, and shortage of professional/skilled surgeons are expected to hamper the market. The shortage of skilled surgeons to perform cardiac surgeries is likely to restrain the market.

Industry analysis.

The global cardiac surgery devices market report will provide an in-depth analysis of the market based on various industry factors such as porter`s five forces, innovations, new product launches, pricing, epidemiological analysis, Etc.

Segment Analysis

The minimally invasive surgery segment is predicted to have a high demand during the forecast period (2022-2029).

The minimally invasive surgery segment is expected to boost the market over the forecast period (2022-2029). Minimally invasive cardiac surgery has surged in popularity because of the various benefits of this procedure, like reduced surgical trauma and decreased pain in the surgical area. Also, recent advancements in minimally invasive surgical approaches are expected to boost the market. For instance, Robotically assisted heart surgery is where the surgeon makes one or more small incisions in the side of the chest and guides robotic arms through these incisions. The robot shows clear images of the heart, and the surgeon controls the robotic arms to perform the procedure.

Geographical Analysis

North America is predicted to command the global cardiac surgery devices market.

North America dominated the global cardiac surgery devices market in 2021. It is estimated to hold a significant market size over the forecast period (2022-2029) owing to the increasing incidences of cardiovascular diseases, rapid technological advances, increasing awareness among the population, and the growing preference for minimally invasive procedures. The increasing incidences of cardiovascular diseases are expected to drive the market over the forecast period. For instance, according to the CDC, every 34 seconds, a U.S. American dies because of cardiovascular disease; in 2020, 697,000 American deaths were caused by cardiovascular disease. Also, among Americans, one person dies from cardiovascular disease every 40 seconds. Coronary heart disease accounts for most CVD deaths, followed by stroke and heart failure. CDC has estimated that heart disease is the leading cause of death in the U.S. and is responsible for 1 in every 5 deaths. Thus, the growing number of cardiovascular diseases drives the cardiac surgery devices market.

Competitive Landscape

The major players operating in the global cardiac surgery devices market are Medtronic, LivaNova plc, Terumo Corporation, Edwards Lifesciences Corporation, Boston Scientific Corporation, Abbott Laboratories, Getinge, Delacroix-Chevalier, Wexler Surgical, Rumex International. The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, which are contributing to the growth of the cardiac surgery devices market globally. For instance, on Apr 08, 2022, LivaNova initiated a targeted commercial launch of the Essenz patient monitor for cardiopulmonary bypass procedures. Also, on July 21, 2022, Terumo India signed a new strategic commercial distribution partnership with Sensible Medical Innovations.

Medtronic, Plc.

Overview:

Medtronic plc is Ireland based American medical device company. Medtronic was founded in 1949 and is headquartered in Minneapolis, Minnesota, United States. Medtronics deals with four different businesses: the Minimally Invasive Therapies Group, the Diabetes Group, the Restorative Therapies Group, and the Cardiac and Vascular Group.

Product Portfolio:

The product portfolio of Medtronic, Plc. The product portfolio for Cardiac Surgery Devices contains Aquamantys bipolar sealers, Monopolar sealers, PlasmaBlade dissection devices, Cardioblate 68000 Surgical Ablation System Generator, Cardioblate Surgical Ablation Pens, Cardioblate™ BP2 , Cardioblate LP, Etc.

The global cardiac surgery devices market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Product Code: DMMD2192

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

4.1. Market Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. The Growing Prevalence of Cardio Vascular Diseases
  - 4.1.1.2. Growing Geriatric Population
  - 4.1.1.3. Market Strategies
- 4.1.2. Restraints
  - 4.1.2.1. Lack of Cardiac Surgeons
  - 4.1.2.2. Stringent Regulation
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of Covid-19 on the Market
- 6.1.1. Before COVID-19 Market Scenario
- 6.1.2. Present COVID-19 Market Scenario
- 6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturer's Strategic Initiatives
6.6. Conclusion

7. By Product Type

7.1. Introduction
- 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
- 7.1.2. Market Attractiveness Index, By Product Type Segment
7.2. Beating Heart Surgery Systems
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  - 7.2.2.1. Stabilizers
  - 7.2.2.2. Positioners
7.3. Perfusion Disposables
- 7.3.1. Oxygenators
- 7.3.2. Centrifugal Pumps
- 7.3.3. Cardioplegia Delivery Systems
7.4. Cardiopulmonary Bypass Equipment
7.5. Catheters
- 7.5.1. Ablation Catheter
- 7.5.2. Drainage Catheter

8. By Procedure

8.1. Introduction
- 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure Segment
- 8.1.2. Market Attractiveness Index, By Procedure Segment
8.2. Coronary Artery Bypass Grafting
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Minimally Invasive Surgery

9. By Type

9.1. Introduction
- 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
- 9.1.2. Market Attractiveness Index, By Type Segment
9.2. Interventional Cardiac Surgery
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Cardiac Rhythm Management
9.4. Traditional Cardiac Surgery
9.5. Others

10. By End User

10.1. Introduction
- 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
- 10.1.2. Market Attractiveness Index, By End User Segment
10.2. Hospitals
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
10.3. Ambulatory Surgical Centers (ASCs)
10.4. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
- 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
- 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
- 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
- 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. The U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
- 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
- 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
- 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
- 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. The U.K.
  - 11.3.7.3. France
  - 11.3.7.4. Italy
  - 11.3.7.5. Spain
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
- 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
- 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
- 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
- 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
- 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
- 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
- 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
- 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. Australia
  - 11.5.7.5. Rest of Asia Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
- 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
- 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
- 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

12.1. Key Developments and Strategies
12.2. Company Share Analysis
12.3. Product Benchmarking

13. Company Profiles

13.1. Medtronic Plc
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Key Highlights
- 13.1.4. Financial Overview
13.2. LivaNova plc
13.3. Terumo Corporation
13.4. Edwards Lifesciences Corporation
13.5. Boston Scientific Corporation
13.6. Abbott Laboratories
13.7. Getinge
13.8. Delacroix-Chevalier
13.9. Wexler Surgical
13.10. Rumex International

LIST NOT EXHAUSTIVE

14. DataM

14.1. Appendix
14.2. About Us and Services
14.3. Contact Us

Global Cardiac Surgery Devices Market - 2022-2029